ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,554Medicare Part D Prescriptions Filled, Including Refills

Rank: 181 out of 917

$516K Total Retail Price of All Prescriptions

Rank: 109 out of 917

327 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 327 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 327 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,278 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 390 276 1 2
OMEPRAZOLE 247 145 2 4
LISINOPRIL 229 175 3 1
LEVOTHYROXINE SODIUM 223 143 4 3
AMLODIPINE BESYLATE 181 140 5 5
METFORMIN HCL 151 96 6 8
CITALOPRAM HBR 140 94 7 15
HYDROCODONE-ACETAMINOPHEN 137 91 S3 8 6
FUROSEMIDE 125 92 9 7
WARFARIN SODIUM 116 95 10 10
LOSARTAN POTASSIUM 114 89 11 13
GABAPENTIN 111 82 12 17
POTASSIUM CHLORIDE 110 67 13 16
CARVEDILOL 109 94 14 33
DONEPEZIL HCL 104 101 15 32
METOPROLOL TARTRATE 103 88 16 11
NAMENDA 98 98 17 43
LYRICA 93 51 18 122
TRAMADOL HCL 93 64 18 28
ATORVASTATIN CALCIUM 86 53 20 14
ZOLPIDEM TARTRATE 83 32 21 21
HYDROCHLOROTHIAZIDE 81 59 22 9
RANITIDINE HCL 81 67 22 29
QUETIAPINE FUMARATE 77 26 24 52
SERTRALINE HCL 75 41 25 24
CLOPIDOGREL 74 62 26 50
FAMOTIDINE 72 61 27 91
MIRTAZAPINE 64 48 28 39
PEN NEEDLE 63 41 29 99
ADVAIR DISKUS 61 44 30 47
DIVALPROEX SODIUM ER 60 36 31 193
SPIRONOLACTONE 59 59 32 55
ALENDRONATE SODIUM 59 57 32 23
TRAZODONE HCL 53 35 34 22
PROAIR HFA 51 36 35 35
TAMSULOSIN HCL 51 48 35 25
CHLORTHALIDONE 51 26 35 113
FINASTERIDE 51 51 35 77
FLUOXETINE HCL 50 37 39 38
METOPROLOL SUCCINATE 50 38 39 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.